Previous Article | Next Article ![]()
Infection and Immunity, August 2006, p. 4452-4461, Vol. 74, No. 8
0019-9567/06/$08.00+0 doi:10.1128/IAI.00666-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, Wisconsin 53226,1 Laboratory of Intracellular Parasites,2 Microscopy Core Unit, NIAID, National Institutes of Health, Rocky Mountain Laboratories, 903 South 4th Street, Hamilton, Montana 598403
Received 25 April 2006/ Returned for modification 19 May 2006/ Accepted 25 May 2006
Francisella tularensis is a facultative intracellular pathogen and is the etiological agent of tularemia. It is capable of escaping from the
phagosome, replicating to high numbers in the cytosol, and inducing
apoptosis in macrophages of a variety of hosts. F. tularensis
has received significant attention recently due to its potential use as
a bioweapon. Currently, there is no licensed vaccine against F.
tularensis, although a partially protective live vaccine strain
(LVS) that is attenuated in humans but remains fully virulent for mice
was previously developed. An F. tularensis LVS mutant deleted
in the purMCD purine biosynthetic locus was constructed and
partially characterized by using an allelic exchange strategy. The
F. tularensis LVS
purMCD mutant was
auxotrophic for purines when grown in defined medium and exhibited
significant attenuation in virulence when assayed in murine macrophages
in vitro or in BALB/c mice. Growth and virulence defects were
complemented by the addition of the purine precursor hypoxanthine or by
introduction of purMCDN in trans. The F.
tularensis LVS
purMCD mutant escaped from the
phagosome but failed to replicate in the cytosol or induce apoptotic
and cytopathic responses in infected cells. Importantly, mice
vaccinated with a low dose of the F. tularensis LVS
purMCD mutant were fully protected against subsequent
lethal challenge with the LVS parental strain. Collectively, these
results suggest that F. tularensis mutants deleted in the
purMCD biosynthetic locus exhibit characteristics that may
warrant further investigation of their use as potential live vaccine
candidates.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»